Evidence map›Paper›PMID 31691059›Full record

ArticleJournal of neuro-oncology2019

Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016.

Roberta Rudà, Alessia Pellerino, Andrea Pace, Carmine Maria Carapella, Cristina Dealis, Manuela Caroli, Marina Faedi, Lorenzo Bello, Enrica Migliore, Giulia Marchese and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Roberta RudàDepartment of Neuro‑Oncology, University and City of Health and Science Hospital, Via Cherasco 15, 10126, Turin, Italy. rudarob@hotmail.com.ORCID 0000-0001-9134-1537
Alessia PellerinoDepartment of Neuro‑Oncology, University and City of Health and Science Hospital, Via Cherasco 15, 10126, Turin, Italy.
Andrea PaceDepartment of Neurosurgery, I.R.C.C.S. Regina Elena National Cancer Institute, Rome, Italy.
Carmine Maria CarapellaDepartment of Neurosurgery, I.R.C.C.S. Regina Elena National Cancer Institute, Rome, Italy.
Cristina DealisDepartment of Medical Oncology, Regional Hospital, Bolzano, Italy.
Manuela CaroliDepartment of Neurosurgery, Regional Hospital, Milan, Italy.
Marina FaediDepartment of Medical Oncology, Regional Hospital, Cesena, Italy.
Lorenzo BelloDepartment of Neurosurgery, University of Milan, Milan, Italy.
Enrica MiglioreUnit of Cancer Epidemiology (CPO Piemonte), University of Turin, Turin, Italy.
Giulia MarcheseDepartment of Neuro‑Oncology, University and City of Health and Science Hospital, Via Cherasco 15, 10126, Turin, Italy.
Luca BerteroDepartment of Biomedical Sciences, University and City of Health and Science Hospital, Turin, Italy.
Paola CassoniDepartment of Biomedical Sciences, University and City of Health and Science Hospital, Turin, Italy.
Riccardo SoffiettiDepartment of Neuro‑Oncology, University and City of Health and Science Hospital, Via Cherasco 15, 10126, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The third and fourth authors' affiliation was incorrectly specified in the original publication. It is correctly shown here.

Identifiers

PMID31691059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.